Here’s what you should know.
1. Cogentix announced in January it agreed to be acquired by Laborie for approximately $239 million.
2. Levi & Korsinsky and Rigrodsky & Long are investigating the sale.
3. When Cogentix Medical President and CEO Darin Hammers referred to the transaction initially, he said, “[It is a] compelling financial opportunity that delivers significant value to our investors who have supported our evolution to becoming a valued player in the urology market.”
4. Neither Cogentix nor Laborie issued a statement in response to the investigation.
More articles on gastroenterology:
Top 10 patient safety concerns for 2018 — diagnostic errors are No. 1
5 things to know about orthopedic surgeon Dr. Shawn Granger
Vanderbilt offers $4.8M for property to build ASC, pediatric clinic — 6 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
